Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 176

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients

Open access
Bertrand, Dominique, Hamzaoui, Mouad, Lemée, Veronique, Lamulle, Julie, Hanoy, Mélanie, Laurent, Charlotte, Lebourg, Ludivine, Etienne, Isabelle, Lemoine, Mathilde, Le Roy, Frank, Nezam, Dorian, Plantier, Jean-Christophe, Boyer, Olivier, Guerrot, Dominique, Candon, Sophie · 2021 · Journal of the American Society of Nephrology

Abstract

Significance Statement: Antibody and T cell responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines are poorly reported in kidney transplant recipients (KTRs) and patients on hemodialysis (HDPs). The authors investigated the response to BNT162b2 vaccine in 45 KTRs and ten HDPs. After the second dose, 88.9% of HDPs and only 17.8% of KTRs developed anti–SARS-CoV-2 antibodies. A specific T cell response was induced in 100% of HDPs and 57.8% of KTRs. The immune response seemed influenced by the immunosuppressive regimen in KTRs, particularly tacrolimus and belatacept. These results could help to better define the strategy of vaccination in this immunocompromised population. Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with a high rate of mortality in patients with ESKD, and vaccination is hoped to prevent infection. Methods: Between January 18 and February 24, 2021, 225 kidney transplant recipients (KTRs) and 45 patients on hemodialysis (HDPs) received two injections of mRNA BNT162b2 vaccine. The postvaccinal humoral and cellular response was explored in the first 45 KTRs and ten HDPs. Results: After the second dose, eight HDPs (88.9%) and eight KTRs (17.8%) developed antispike SARS-CoV-2 antibodies (P<0.001). Median titers of antibodies in responders were 1052 AU/ml (IQR, 515–2689) in HDPs and 671 AU/ml (IQR, 172–1523) in KTRs (P=0.40). Nine HDPs (100%) and 26 KTRs (57.8%) showed a specific T cell response (P=0.06) after the second injection. In responders, median numbers of spike-reactive T cells were 305 SFCs per 10 6 CD3+ T cells (IQR, 95–947) in HDPs and 212 SFCs per 10 6 CD3+ T cells (IQR, 61–330) in KTRs (P=0.40). In KTRs, the immune response to BNT162b2 seemed influenced by the immunosuppressive regimen, particularly tacrolimus or belatacept. Conclusion: Immunization with BNT162b2 seems more efficient in HDPs, indicating that vaccination should be highly recommended in these patients awaiting a transplant. However, the current vaccinal strategy for KTRs may not provide effective protection against COVID-19 and will likely need to be improved.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2021040480

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 176

Metadata

Authors
Bertrand, D., Hamzaoui, M., Lemée, V., Lamulle, J., Hanoy, M., Laurent, C., Lebourg, L., Etienne, I., Lemoine, M., Le Roy, F., Nezam, D., Plantier, J.-C., Boyer, O., Guerrot, D., & Candon, S.
Venue
Journal of the American Society of Nephrology
Published
2021-09
Volume
32
Issue
9
Pages
2147-2152
ISSN
  • 1046-6673 (ISSN-L)
  • 1533-3450
OpenAlex
W3170537423
Cited by
176
References
2
FWCI
12.29
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients. https://app.cochat.ai/papers/10.1681/asn.2021040480
The paper
Bertrand, D., Hamzaoui, M., Lemée, V., Lamulle, J., Hanoy, M., Laurent, C., Lebourg, L., Etienne, I., Lemoine, M., Le Roy, F., Nezam, D., Plantier, J.-C., Boyer, O., Guerrot, D., & Candon, S. (2021). Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2021040480

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.